Cargando…

Hand-foot syndrome caused by capecitabine: incidence, risk factors and the role of dermatological evaluation

Hand-foot syndrome (HFS), or palmar-plantar erythrodysesthesia, is characterised by erythema, oedema and dysesthesia, which can progress to blistering and ulceration. This condition is described as a common adverse effect of the chemotherapeutic agent capecitabine. The study set out to evaluate real...

Descripción completa

Detalles Bibliográficos
Autores principales:	de Queiroz, Marina Vieira Rodrigues, de Medeiros, Ana Carolina Tardin Rodrigues, Toledo, Sarah Pires, de Abreu Sarmenghi, Karina Demoner, de Vasconcellos, Vitor Fiorin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cancer Intelligence 2022
Materias:	Clinical Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9300399/ https://www.ncbi.nlm.nih.gov/pubmed/35919225 http://dx.doi.org/10.3332/ecancer.2022.1390

Ejemplares similares

Acute localized exanthematous pustulosis induced by paclitaxel()
por: Medeiros, Ana Carolina Tardin Rodrigues de, et al.
Publicado: (2022)

Thalidomide in plasma cell balanitis refractory to conventional topical treatment
por: Serrão, Lucas Mariano, et al.
Publicado: (2018)

HAND-FOOT SYNDROME DUE TO CAPECITABINE
por: Surjushe, Amar, et al.
Publicado: (2009)

HAND-FOOT SYNDROME DUE TO CAPECITABINE
por: Surjushe, Amar, et al.
Publicado: (2008)

Classic and Simultaneous Clinical Findings of an Exuberant Case of Netherton Syndrome: A Clinical Report
por: Schultz Junior, Ademar, et al.
Publicado: (2021)

Capecitabine-induced oral mucosal hyperpigmentation associated with hand-foot syndrome – A literature review()
por: Nascimento, Anna Danielly Almeida do, et al.
Publicado: (2023)

Scleroderma in a Patient on Capecitabine: Is this a Variant of Hand-Foot Syndrome?
por: Saif, Muhammad W, et al.
Publicado: (2016)

Hyperpigmentation with Capecitabine: Part of Hand-Foot Syndrome or a Separate Entity?
por: Caprez, Jennifer, et al.
Publicado: (2018)

Generalised Lichenoid Drug Eruption Accompanied by Hand-foot Syndrome Due to Capecitabine
por: Tamer, Funda, et al.
Publicado: (2018)

Hand-Foot Syndrome Presentation Post-Capecitabine Treatment in a Black Patient
por: Whorton, Allison E, et al.
Publicado: (2022)

Hand-Foot Syndrome with Scleroderma-like Change Induced by the Oral Capecitabine: A Case Report
por: Lee, Sehe-Dong, et al.
Publicado: (2007)

Henna Application in the Prevention of Capecitabine-Induced Hand-Foot Syndrome in Breast and Colorectal Cancer Patients
por: Kayikci, Emel Emine, et al.
Publicado: (2020)

Polymorphisms in TYMS for Prediction of Capecitabine-Induced Hand-Foot Syndrome in Chinese Patients with Colorectal Cancer
por: Dong, Si-Qi, et al.
Publicado: (2021)

Precision oncology: as much expectations as limitations
por: Vasconcellos, Vitor Fiorin, et al.
Publicado: (2018)

An unusual case of capecitabine hyperpigmentation: Is hyperpigmentation a part of hand-foot syndrome or a separate entity?
por: Vasudevan, Biju
Publicado: (2010)

Compliance and Effective Management of the Hand-Foot Syndrome in Colon Cancer Patients Receiving Capecitabine as Adjuvant Chemotherapy
por: Son, Hyun-Sook, et al.
Publicado: (2009)

Treatment of capecitabine-induced hand-foot syndrome using a topical retinoid: A case report
por: INOKUCHI, MASAFUMI, et al.
Publicado: (2014)

Polymorphisms of MTHFR and TYMS predict capecitabine-induced hand-foot syndrome in patients with metastatic breast cancer
por: Lin, Shaoyan, et al.
Publicado: (2019)

Use of omeprazole, the proton pump inhibitor, as a potential therapy for the capecitabine-induced hand-foot syndrome
por: Hiromoto, Shiori, et al.
Publicado: (2021)

Stevens-Johnson syndrome and concurrent hand foot syndrome during treatment with capecitabine: A case report
por: Ahn, Ha Rim, et al.
Publicado: (2021)

Capecitabine-associated hand–foot–skin reaction is an independent clinical predictor of improved survival in patients with colorectal cancer
por: Hofheinz, R-D, et al.
Publicado: (2012)

Evaluation of patient-reported severity of hand–foot syndrome under capecitabine using a Markov modeling approach
por: Schmulenson, Eduard, et al.
Publicado: (2020)

Genetic variation in ST6GAL1 is a determinant of capecitabine and oxaliplatin induced hand‐foot syndrome
por: Watts, Katie, et al.
Publicado: (2022)

Hand, foot, and mouth syndrome in an immunocompetent adult: a case report
por: Flor de Lima, Bárbara, et al.
Publicado: (2013)

Inpatient palliative chemotherapy is associated with high mortality and aggressive end-of-life care in patients with advanced solid tumors and poor performance status
por: Fiorin de Vasconcellos, Vitor, et al.
Publicado: (2019)

Syndrome in question: Gorlin-Goltz syndrome
por: Ribeiro, Pauline Lyrio, et al.
Publicado: (2016)

Topical heparin as an effective and safe treatment for patients with capecitabine-induced hand-foot syndrome: results of a phase IIA trial supported by proteomic profiling of skin biopsies
por: Rodríguez-Garzotto, Analia, et al.
Publicado: (2022)

Coxsackievirus A6 strains causing an outbreak of hand-foot-and-mouth disease in Northeastern Brazil in 2018
por: Luchs, Adriana, et al.
Publicado: (2022)

Oral hyperpigmentation as an initial clinical aspect of hand foot syndrome
por: dos Santos-Leite, Éder Gerardo, et al.
Publicado: (2022)

Predictive role of hand–foot syndrome in patients receiving first-line capecitabine plus bevacizumab for HER2-negative metastatic breast cancer
por: Zielinski, Christoph, et al.
Publicado: (2016)

Randomized double-blind, placebo-controlled study of topical diclofenac in the prevention of hand-foot syndrome in patients receiving capecitabine (the D-TORCH study)
por: Santhosh, Akhil, et al.
Publicado: (2022)

Development of a New Tool to Assess the Quality of Life of Patients with Hand–Foot Syndrome Receiving Capecitabine-Based Therapy: A Pilot Study
por: Jagdish, Prathepa, et al.
Publicado: (2022)

Hand instrumentation provides improved tissue response over ultrasonic scaler and substantiates safe dental practice: An in vivo study in rats
por: de Almeida, Juliano Milanezi, et al.
Publicado: (2023)

Satisfaction of Patients Undergoing Hand Surgery
por: Camargo, Victória Muller de, et al.
Publicado: (2022)

A case of hand-foot syndrome with olaparib
por: da Costa, Rafael Everton Assunção Ribeiro, et al.
Publicado: (2022)

Risk Factors for Foot Amputation in Patients Hospitalized for Diabetic Foot Infection
por: Verrone Quilici, Maria Teresa, et al.
Publicado: (2016)

Oral and Topical Probiotics and Postbiotics in Skincare and Dermatological Therapy: A Concise Review
por: De Almeida, Carolina Vieira, et al.
Publicado: (2023)

Seasonality of the hospitalizations at a dermatologic ward (2007-2017)
por: Brito, Leonardo de Andrade Rodrigues, et al.
Publicado: (2018)

Effect of Chinese Herbal Compound LC09 on Patients With Capecitabine-Associated Hand-Foot Syndrome: A Randomized, Double-Blind, and Parallel-Controlled Trial
por: Yu, Ran, et al.
Publicado: (2020)

Brazilian Society of Dermatology against leprosy
por: Lastória, Joel Carlos, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_evpc7n4c8coorsoo37329p9d8i